Docetaxel and gemcitabine released for cancer chemotherapy.  [electronic resource] 

 -  American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists  Jul 1996 
 - 1643, 1649 p.  digital 
<br/><br/> Publication Type: News 
<br/><br/><label>ISSN: </label>1079-2082 
<br/><br/><label>Standard No.: </label>10.1093/ajhp/53.14.1643  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antimetabolites, Antineoplastic--therapeutic use<br/>Antineoplastic Agents, Phytogenic--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Deoxycytidine--analogs & derivatives<br/>Docetaxel<br/>Drug Approval<br/>Humans<br/>Paclitaxel--analogs & derivatives<br/>Pancreatic Neoplasms--drug therapy<br/>Taxoids<br/>United States<br/>United States Food and Drug Administration<br/>Gemcitabine